Nanosphere has signed a distribution and collaboration agreement with Hitachi High-Technologies.
Subscribe to our email newsletter
With the agreement, Hitachi High-Technologies will gain exclusive rights to market Nanosphere products in Japan. The two companies also plan to collaborate on assay and platform development.
Hitachi High-Tech general manager Kazuhiro Matsumura said that Nanosphere’s portfolio of molecular diagnostics tests fits well with Japan’s demand for rapid and accurate diagnostic tools to fight infections, enabling clinicians to target therapies potentially improving critical patient care and outcomes.
"Nanosphere’s portfolio of molecular diagnostics tests fits well with Japan’s demand for rapid and accurate diagnostic tools to fight infections, enabling clinicians to target therapies potentially improving critical patient care and outcomes," Matsumura added.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.